ICPT Historical PE Ratio image   This ICPT PE ratio history page last updated 8/5/2022
ICPT Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/3/2022
13.84-0.25-1.00NA
Q1 2022
5/6/2022
19.27-0.58-2.32NA
Q4 2021
3/2/2022
13.56-1.23-4.92NA
Q3 2021
11/3/2021
19.34-0.63-2.52NA
Q2 2021
7/29/2021
17.24-0.33-1.32NA
Q1 2021
5/6/2021
17.01-1.22-4.88NA
Q4 2020
2/25/2021
23.05-1.58-6.32NA
Q3 2020
11/9/2020
34.84-1.61-6.44NA
Q2 2020
8/10/2020
52.83-1.92-7.68NA
Q1 2020
5/11/2020
90.44-2.86-11.44NA
Q4 2019
2/25/2020
84.68-2.99-11.96NA
Q3 2019
11/5/2019
74.52-2.59-10.36NA
Q2 2019
8/7/2019
61.51-2.28-9.12NA
Q1 2019
5/8/2019
87.57-3.03-12.12NA
Q4 2018
2/28/2019
99.74-2.97-11.88NA
Q3 2018
10/31/2018
96.01-2.18-8.72NA
Q2 2018
8/2/2018
100.83-2.58-10.32NA
Q1 2018
5/8/2018
70.15-3.22-12.88NA
Q4 2017
2/14/2018
56.02-4.43-17.72NA
Q3 2017
11/1/2017
64.86-2.89-11.56NA
Q2 2017
7/31/2017
117.13-3.46-13.84NA
Q1 2017
5/4/2017
117.29-3.61-14.44NA
Q4 2016
2/23/2017
115.93-4.84-19.36NA
Q3 2016
11/3/2016
98.20-3.59-14.36NA
Q2 2016
8/4/2016
163.21-3.14-12.56NA
Q1 2016
5/5/2016
136.99-5.17-20.68NA
Q4 2015
2/25/2016
112.27-3.62-14.48NA
Q3 2015
11/9/2015
192.29-2.10-8.40NA
Q2 2015
8/5/2015
260.13-1.99-7.96NA
Q1 2015
5/11/2015
280.27-1.78-7.12NA
Q4 2014
3/2/2015
225.54-1.63-6.52NA
Q3 2014
11/7/2014
172.59-1.69-6.76NA
Q2 2014
8/11/2014
237.181.516.0439.3
Q1 2014
5/7/2014
254.48-13.21-52.84NA
Q4 2013
3/14/2014
462.26-0.64-2.56NA
Q3 2013
11/14/2013
49.09-1.74-6.96NA
Q2 2013
8/13/2013
46.08-0.79-3.16NA
Q1 2013
5/14/2013
31.57-0.62-2.48NA
Q4 2012
3/18/2013
36.48-2.02-8.08NA
Q3 2012
11/5/2012
19.27-1.86-7.44NA
ICPT PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/3/2022
13.84-0.25-2.69NA
Q1 2022
5/6/2022
19.27-0.58-2.77NA
Q4 2021
3/2/2022
13.56-1.23-3.41NA
Q3 2021
11/3/2021
19.34-0.63-3.76NA
Q2 2021
7/29/2021
17.24-0.33-4.74NA
Q1 2021
5/6/2021
17.01-1.22-6.33NA
Q4 2020
2/25/2021
23.05-1.58-7.97NA
Q3 2020
11/9/2020
34.84-1.61-9.38NA
Q2 2020
8/10/2020
52.83-1.92-10.36NA
Q1 2020
5/11/2020
90.44-2.86-10.72NA
Q4 2019
2/25/2020
84.68-2.99-10.89NA
Q3 2019
11/5/2019
74.52-2.59-10.87NA
Q2 2019
8/7/2019
61.51-2.28-10.46NA
Q1 2019
5/8/2019
87.57-3.03-10.76NA
Q4 2018
2/28/2019
99.74-2.97-10.95NA
Q3 2018
10/31/2018
96.01-2.18-12.41NA
Q2 2018
8/2/2018
100.83-2.58-13.12NA
Q1 2018
5/8/2018
70.15-3.22-14.00NA
Q4 2017
2/14/2018
56.02-4.43-14.39NA
Q3 2017
11/1/2017
64.86-2.89-14.80NA
Q2 2017
7/31/2017
117.13-3.46-15.50NA
Q1 2017
5/4/2017
117.29-3.61-15.18NA
Q4 2016
2/23/2017
115.93-4.84-16.74NA
Q3 2016
11/3/2016
98.20-3.59-15.52NA
Q2 2016
8/4/2016
163.21-3.14-14.03NA
Q1 2016
5/5/2016
136.99-5.17-12.88NA
Q4 2015
2/25/2016
112.27-3.62-9.49NA
Q3 2015
11/9/2015
192.29-2.10-7.50NA
Q2 2015
8/5/2015
260.13-1.99-7.09NA
Q1 2015
5/11/2015
280.27-1.78-3.59NA
Q4 2014
3/2/2015
225.54-1.63-15.02NA
Q3 2014
11/7/2014
172.59-1.69-14.03NA
Q2 2014
8/11/2014
237.181.51-14.08NA
Q1 2014
5/7/2014
254.48-13.21-16.38NA
Q4 2013
3/14/2014
462.26-0.64-3.79NA
Q3 2013
11/14/2013
49.09-1.74-5.17NA
Q2 2013
8/13/2013
46.08-0.79-5.29NA
Q1 2013
5/14/2013
31.57-0.62NANA
Q4 2012
3/18/2013
36.48-2.02NANA
Q3 2012
11/5/2012
19.27-1.86NANA
Quotes delayed 20 minutes

Email EnvelopeFree ICPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Intercept Pharmaceuticals (ICPT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ICUI PE Ratio History
ICVX PE Ratio History
IDRA PE Ratio History
IDXX PE Ratio History
IDYA PE Ratio History
IGMS PE Ratio History
IIN PE Ratio History
IKNA PE Ratio History
IKT PE Ratio History
ILMN PE Ratio History
How should the ICPT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Intercept Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ICPT Historical PE Ratio page.

What is the average historical PE for ICPT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ICPT historical PE ratio using the annualized quarterly earnings method works out to 39.3.

What is the average historical PE for ICPT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ICPT historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ICPT Historical PE Ratio information for Intercept Pharmaceuticals' stock. The average ICPT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 39.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ICPT historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ICPT historical PE result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for ICPT had been 15.65, and the most recent quarterly earnings result, annualized, was 6.04. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent ICPT PE on 8/4/2022 based on annualized quarterly EPS was 2.6. Based on ICPT's history, that recent PE is low relative to the historical average, with the recent PE 93.4% lower than the historical average PE across our data set for Intercept Pharmaceuticals.

For self directed investors doing their due diligence on ICPT or any other given stock, valuation analysis for ICPT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Intercept Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ICPT. Thanks for visiting, and the next time you need to research ICPT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of APTS, Funds Holding UJUN, PNRA Videos.

 

ICPT Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.